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Estimated risk of placental infection and low birthweight 
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2010: a modelling study
Patrick G T Walker, Feiko O ter Kuile, Tini Garske, Clara Menendez, Azra C Ghani
Summary
Background Plasmodium falciparum infection during pregnancy leads to adverse outcomes including low birthweight; 
however, contemporary estimates of the potential burden of malaria in pregnancy in Africa (in the absence of 
interventions) are poor. We aimed to estimate the need to protect pregnant women from malaria across Africa.
Methods Using a mathematical model applied to estimates of the geographical distribution of P falciparum across 
Africa in 2010, we estimated the number of pregnant women who would have been exposed to infection that year in 
the absence of pregnancy-speciﬁ c intervention. We then used estimates of the parity-dependent acquisition of 
immunity to placental infection and associated risk of low birthweight to estimate the number of women who would 
have been aﬀ ected.
Findings We estimate that, without pregnancy-speciﬁ c protection, 12∙4 million pregnant women (44∙9% of all 
27∙6 million livebirths in malaria endemic areas in Africa in 2010) would have been exposed to infection, with 
11∙4 million having placental infection (41∙2% of all livebirths). This infection leads to an estimated 900 000 (95% credible 
interval [CrI] 530 000–1 240 000) low birthweight deliveries per year. Around the end of the ﬁ rst trimester, when the 
placenta becomes susceptible to infection, is a key period during which we estimate that 65∙2% (95% CrI 60∙9–70∙0) of 
placental infections ﬁ rst occur.
Interpretation Our calculations are the only contemporary estimates of the geographical distribution of placental 
infection and associated low birthweight. The risk of placental infection across Africa in unprotected women is high. 
Prevention of malaria before conception or very early in pregnancy is predicted to greatly reduce incidence of low 
birthweight, especially in primigravidae. The underlying lifetime risk of low birthweight changes slowly with 
decreasing transmission, drawing attention to the need to maintain protection as transmission falls.
Funding Malaria in Pregnancy Consortium and the Bill & Melinda Gates Foundation.
Copyright © Walker et al. Open Access article distributed under the terms of CC BY.
Introduction
Plasmodium falciparum malaria infection during pregnancy 
leads to infected erythrocytes sequestering within the 
placenta.1 This placental infection can have severe 
consequences for both mother and child, causing maternal 
anaemia, intrauterine growth restriction, preterm delivery, 
and fetal death.2 The prevalence and consequences of 
malaria in pregnancy are uniquely parity-dependent 
because women acquire adaptive immunity that restricts 
the extent of placental infection with successive infected 
pregnancies.3 Understanding of the risk of infection 
during pregnancy, and the associated burden of low 
birthweight (LBW; <2500 g) this infection can cause, and 
how this burden varies across the wide range of 
transmission intensities of P falciparum in Africa, is of 
high priority in assessment of the importance of protection 
of pregnant women from malaria.
A 2010 analysis4 used estimates of the global 
distribution of P falciparum transmission5 to calculate 
that 31∙3 million pregnancies and 22∙8 million livebirths 
occur in areas of stable transmission in Africa. Although 
this analysis provided a useful indication of the potential 
scope of the population at risk, it did not include 
estimates of the actual risk of malaria infection in 
pregnancy and the various heterogeneities in the 
likelihood and consequences of infection in pregnant 
women across Africa. Nor did this calculation of risk 
indicate the fact that, especially in areas of high 
transmission, women with high parity have much lower 
risk of the adverse consequence of malaria infection than 
do those with low parity, because of immunity acquired 
from infection during previous pregnancies. Previous 
estimates of the burden of malaria-attributable LBW,6,7 an 
important risk factor for infant morbidity and mortality,8 
similarly did not take into account heterogeneity in 
transmission or parity-dependent eﬀ ects on birthweight. 
These estimates also relied on infection measured by 
parasites in the placenta at delivery; therefore they do not 
adequately take into account the eﬀ ect of infections early 
in pregnancy, which are a strong risk factor for LBW.9,10 
These early infections are best captured with placental 
histology,11 which enables identiﬁ cation of both active 
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infections and cleared infections (through the persistence 
of malaria pigment in the placenta).
To accurately estimate the need to protect pregnant 
women from malaria, we ﬁ tted an existing mathematical 
model of the dynamics of P falciparum to high-resolution 
prevalence estimates across Africa and, using 
country-speciﬁ c fertility data, estimated the number of 
pregnant women who would have been exposed to malaria 
during pregnancy in 2010, in the absence of protection 
from infection during pregnancy. We then combined 
these estimates with a model of placental infection, 
incorporating the associated risk of LBW, to capture the 
parity dependence of the risk of infection. This second 
step is limited by the fact that only two large-scale datasets 
of placental histology and LBW before large-scale 
interventions have been published.12,13 However, we believe 
that incorporation of the best available quantitative 
estimate of this fundamental aspect of the epidemiology 
of malaria in pregnancy, and how this relates to the level 
of transmission within a population, enable us to provide 
a nuanced and up-to-date estimate of the burden of 
malaria in pregnancy and the potential eﬀ ect of successful 
prevention of malaria in this high-risk group.
Methods
Modelling of exposure and infection during pregnancy
We mapped the risk of placental infection with 
P falciparum by parity across a 0·1 by 0·1 grid across 
Africa using a mathematical model that takes into 
account estimates of the intensity of transmission and 
fertility patterns within each grid square (appendix).14 
We back-calculated the intensity of transmission in each 
pixel from the posterior median estimates of parasite 
prevalence in 2–10-year-old children in 2010,15 using a 
relation between measured prevalence and entomo-
logical inoculation rate (EIR) obtained from ﬁ tting to 
data from an extensive range of transmission settings.14,16 
We calculated age-speciﬁ c and parity-speciﬁ c fertility 
rates for each pixel, stratiﬁ ed by urban and rural 
residence, from the most recent national population-
based (Demographic and Health Survey, Malaria 
Indicator Survey, or AIDS Indicator Survey) surveys.17 
We calculated population estimates for 2010, and the 
proportion of the population living in urban or rural 
areas, using the method detailed by Cairns and 
colleagues.17 We then weighted overall fertility patterns 
in each pixel using urban-speciﬁ c or rural-speciﬁ c 
national fertility rates and population proportions. For 
countries with no post-2002 survey data (Botswana, 
Central African Republic, Djibouti, Equatorial Guinea, 
Eritrea, Gabon, The Gambia, Guinea-Bissau, Mauritania, 
Togo, Somalia, South Africa, South Sudan, and Sudan) 
we calculated fertility patterns using the rates of the 
country nearest to each pixel. We then ran the 
mathematical model for placental infection,14 which also 
enables estimation of the risk of exposure to infection 
during pregnancy, using the estimated EIR and fertility 
pattern in each pixel, calculated assuming a mortality 
rate of 0∙9% per year,19 to obtain the risk of placental 
infection at any stage of pregnancy.
We calculated the number of women of child-bearing 
age in each pixel by multiplying the estimated population 
by the national estimate of the proportion of the population 
who are female and aged 15–49 years from country-speciﬁ c 
UN demographic information.20 We then multiplied this 
ﬁ gure by the average number of lifetime pregnancies and 
divided the result by the assumed reproductive lifespan 
(35 years) to obtain the yearly number of pregnancies 
resulting in livebirths exposed to infection (deﬁ ned as 
having a prevalent infection at the time the placenta 
develops, or having a peripheral infection at a later stage 
of gestation) and the total having placental infection in 
each pixel. This number was summed over all pixels to 
estimate the number of deliveries leading to livebirths to 
women infected during pregnancy in Africa projected for 
2010, overall and by parity group. We repeated this analysis 
for 200 draws from the joint posterior distribution of our 
model, which enabled construction of credible intervals 
First pregnancy Second pregnancy Third pregnancy All pregnancies






























<10% 1374 11·7% 1·4% 1163 11·5% 1·2% 947 11·4% 1·1% 5·6 11·4% 1·1%
10–20% 555 36·8% 4·5% 502 34·4% 3·5% 439 32·0% 2·7% 2·7 31·4% 2·7%
20–30% 529 51·0% 6·5% 491 46·5% 4·7% 441 42·1% 3·2% 2·8 40·9% 3·3%
30–40% 854 59·8% 7·9% 790 53·7% 5·3% 709 48·2% 3·4% 4·5 47·0% 3·7%
40–50% 1083 66·2% 9·0% 1010 59·5% 5·7% 916 53·3% 3·5% 5·8 51·7% 3·9%
50–60% 799 71·3% 10·0% 742 64·2% 6·1% 660 58·0% 3·6% 4·1 56·8% 4·3%
60–70% 347 76·6% 11·1% 323 69·7% 6·5% 290 63·6% 3·7% 1·8 62·0% 4·5%
>70% 39 81·5% 12·4% 32 75·2% 6·8% 32 69·5% 3·8% 0·2 67·8% 4·9%
Prevalence strata calculated by Malaria Atlas Project-estimated slide prevalence in children aged 2–10 years. *LBW risk attributable to placental infection. 
Table 1: Estimated burden of infection and malaria-attributable low birthweight (LBW) by prevalence (transmission intensity) strata in Africa
See Online for appendix
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(CrIs), providing an indication of the uncertainty inherent 
in our estimates of parity-dependent immunity. Further 
analysis of the level of uncertainty attributable to Malaria 
Atlas Project-based estimates of parasite prevalence and of 
the relation between prevalence and intensity of infection 
was not computationally feasible.
Incorporation of LBW into model
To estimate the incremental risk of LBW posed by the 
diﬀ erent placental infection categories, we extended the 
model to obtain a relation between parity-speciﬁ c and 
histology-speciﬁ c placental infection categories and the 


















in ﬁ rst pregnancy
Angola 298 374 270 503 19 968 19% 21% 38%
Benin 227 247 206 793 15 641 21% 23% 43%
Botswana 5126 4965 494 27% 27% 33%
Burkina Faso 407 404 369 514 27 864 23% 25% 48%
Burundi 113 245 106 704 9274 21% 22% 31%
Cameroon 436 292 398 117 31 180 24% 26% 47%
CAR 128 241 115 710 8449 21% 23% 43%
Chad 218 576 200 426 15 452 20% 22% 37%
CÔte d’Ivoire 361 912 333 946 27 981 28% 30% 50%
Djibouti 797 786 84 38% 39% 41%
DRC 1 501 677 1 358 364 99 373 20% 22% 40%
Equatorial Guinea 14 111 12 851 1002 24% 27% 48%
Eritrea 14 284 13 863 1388 26% 26% 31%
Ethiopia 235 988 228 972 22 881 25% 26% 30%
Gabon 45 554 40 706 2941 20% 23% 44%
The Gambia 16 406 15 611 1426 24% 25% 33%
Ghana 370 514 346 966 30 616 29% 31% 47%
Guinea 213 778 195 950 15 257 22% 24% 40%
Guinea-Bissau 17 628 16 628 1467 22% 24% 33%
Kenya 147 559 140 392 13 298 29% 31% 42%
Liberia 76 322 70 171 5638 24% 26% 44%
Madagascar 263 619 245 169 20 831 26% 28% 44%
Malawi 295 588 271 655 21 764 23% 25% 43%
Mali 354 503 317 071 22 108 19% 21% 42%
Mauritania 31 458 29 329 2446 19% 20% 30%
Mozambique 590 301 539 791 39 504 20% 22% 42%
Namibia 15 760 15 047 1422 29% 30% 40%
Niger 301 726 274 391 20 241 19% 21% 37%
Nigeria 3 311 949 3 024 553 232 403 21% 23% 42%
Republic of Congo 72 776 67 601 5736 27% 29% 46%
Rwanda 28 722 27 899 2809 26% 27% 32%
Senegal 104 623 99 320 8996 22% 23% 31%
Sierra Leone 135 298 124 775 10 222 25% 27% 45%
Somalia 29 208 28 331 2823 25% 26% 30%
South Africa 48 987 46 980 4462 25% 26% 33%
Sudan (including South Sudan) 424 707 398 681 34 194 22% 23% 33%
Swaziland 367 352 34 29% 30% 37%
Tanzania 496 605 460 849 38 104 22% 24% 37%
Togo 152 643 139 215 10 715 22% 25% 44%
Uganda 630 085 577 616 45 711 23% 25% 43%
Zambia 192 154 176 690 13 761 19% 20% 33%
Zimbabwe 72 625 70 102 6875 26% 26% 32%
DRC=Democratic Republic of Congo. CAR=Central African Republic.
Table 2: Estimated burden of infection and malaria-attributable low birthweight (LBW) by country
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which might vary in diﬀ ering settings (see appendix for 
full details of how the relation between infection and LBW 
was ﬁ tted to data from Ifakara, Tanzania,12 and Kiliﬁ , 
Kenya13). Notably, this approach means that our estimate 
of malaria-attributable LBW will include deliveries that 
would already have been LBW in the absence of infection. 
However, because the consequences of LBW are more 
severe the lower the weight, with very low birthweight 
babies (<2000 g) at greatest risk of neonatal mortality,21 it 
seems reasonable to assume that deliveries already 
destined to be LBW, which then receive suﬃ  cient exposure 
to placental infection to cause malaria-attributable LBW, 
are likely to be at great risk of negative birth outcomes due 
to malaria, especially if malaria contributes to further 
reduction of birthweight. As a result, we believe that to 
count these deliveries within our estimates of LBW 
attributable to malaria is likely to be a good indication of 
the underlying morbidity caused by malaria. We did our 
analyses using C++ and the R statistical package.
Role of the funding source
The funders had no role in study design, collection, 
analysis, and interpretation of the data, writing of the 
Article, or the decision to submit the Article for publication.
Results
We estimate that, in 2010, from a total of 27∙6 million 
pregnancies leading to livebirths occurring in malaria-
endemic areas in Africa, 12∙4 million (44∙9%) would 
have been exposed to infection if not speciﬁ cally 
protected. Taking into account the eﬀ ects of parity-
dependent immunity, we estimate that 41∙2% (95% CrI 
38∙8–43∙8) or 11∙4 million (10∙7–12∙1 million) women 
would have had placental infection at some stage during 
pregnancy. Our estimates show substantial geographical 
variation in these statistics, mainly due to heterogeneity 
in transmission intensity, with prevalence of placental 
infection in pregnant women ranging from 73% along 
the Nigeria–Cameroon border to 2% in the Kenyan 
highlands. Tables 1 and 2 show the distribution of these 
pregnancies by transmission intensity strata and country. 
Primigravidae were at the highest risk of placental 
infection, with an estimated 2∙7 million (48∙2%) of 
5∙6 million ﬁ rst pregnancies infected, although risk of 
infection during pregnancy was high in multigravidae, 
with 8∙7 million (39∙5%) of 22·0 million pregnancies 
infected. The proportion of women potentially exposed to 
and having placental infection during pregnancy 
increases with transmission intensity (ﬁ gures 1D and 2D, 
tables 1 and 2). Placental infection prevalence decreases 
with parity (ﬁ gure 2A–C), because women acquire 
parity-dependent immunity, and a higher degree of 
age-dependent immunity, and are therefore better able to 
clear infection than are women of lower parity.
Figure 3 shows our estimates of the timing of infection 
during gestation. In the absence of malaria in pregnancy-
speciﬁ c interventions, 65∙2% (95% CrI 60∙9–70∙0) of 
Figure 1: Exposure to infection during pregnancy across Africa
Per-pregnancy risk of being exposed to Plasmodium falciparum infection during pregnancy in the absence of 
interventions, according to diﬀ erent parity strata: ﬁ rst pregnancy (A), second pregnancy (B), third pregnancy (C), 
fourth pregnancy and risk averaged over all pregnancies (D). 
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C D





Figure 2: Estimated risk of placental infection during pregnancy across Africa
Per-pregnancy risk of at least one placental infection during gestation in the absence of interventions, according to 
diﬀ erent parity strata: ﬁ rst pregnancy (A), second pregnancy (B), third pregnancy (C), fourth pregnancy and risk 
averaged over all pregnancies (D).
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placental infections are estimated to occur early in 
gestation, when the placenta reaches the stage of 
development at which it can be parasitised by an ongoing 
infection (in our model this point is assumed to be at 
12 weeks’ gestation,14 but could occur as early as at 
7 weeks22). Subsequently throughout pregnancy, the 
incidence of placental infection is directly related to the 
incidence of peripheral infection, which is much lower 
and, as a consequence of our model assumptions, is 
constant until delivery. We also did a sensitivity analysis 
of the potential eﬀ ect of seasonality on these estimates 
(appendix). The risk of placental infection early in 
pregnancy varies with transmission season, with women 
who deliver about 30 weeks after the seasonal peak being 
most likely to have had an ongoing infection when their 
placenta ﬁ rst becomes susceptible. However, when we 
controlled for prevalence in children aged 2–10 years and 
assumed constant overall fertility, this seasonal variation 
did not substantially change our estimates of the 
averaged risk across the year (appendix).
Because of the absence of parity-dependent immunity, 
primigravidae are estimated to have more prolonged 
placental infection. Untreated, infected primigravidae 
spent, on average, 120∙4 days (95% CrI 113∙5–125∙8) with 
placental infection, compared with 83∙3 days (74∙7–95∙4) 
in multigravidae. This longer period is likely to cause, or 
at least indicate, an inﬂ ammatory immune response 
liable to lead to LBW.
The appendix shows the data and ﬁ tted model for the 
association between placental infection and LBW risk in 
Kiliﬁ , Kenya, and Ifakara, Tanzania. In both settings the 
risk of a LBW delivery was associated with the diﬀ erent 
placental infection categories, and the risk of being 
infected at delivery (evidence of either acute or chronic 
infection) is highest for primigravidae. In Kiliﬁ , where 
transmission was less intense, a degree of placental 
infection-attributable risk of LBW in paucigravidae 
(gravidae 2–4; appendix) seems to exist, whereas in 
Ifakara, where transmission intensity was higher, the 
association between risk of LBW and the diﬀ erent 
placental infection categories in paucigravidae was weaker, 
and absent in grand-multigravidae, suggesting that 
malaria might have little eﬀ ect on birthweight in most 
multigravid women in this setting (appendix). By contrast, 
the risk of LBW by infection stage, particularly among 
previously unexposed primigravidae, seems to follow a 
consistent pattern across both transmission settings, with 
women with chronic infection at delivery at highest risk of 
LBW at delivery, and those with evidence of past infection 
at higher risk than those whose placentas were not infected 
(drawing attention to the requirement to capture the role 
of early infection within our model). By contrast, across 
both settings, acute infection by histology at delivery and 
the risk of LBW seem to have very little association.
Of all the combinations of variables tested (appendix), 
we noted that a model in which LBW risk depends solely 
on the duration of chronic infection during pregnancy, 
and which is estimated to be most aﬀ ected by the 
acquisition of parity-dependent immunity,14 provided the 
closest ﬁ t to these observed patterns of LBW (ﬁ gure 4).
Figure 3: Risk of incidental placental infection by stage of gestation
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We estimated that 900 000 (95% CrI 530 000–1 240 000) 
malaria-attributable LBW deliveries in the absence of 
pregnancy-speciﬁ c interventions occurred in Africa in 
2010. Figure 4 shows how this risk varies spatially and by 
parity. LBW risk is estimated to be strongly concentrated 
in women having their ﬁ rst pregnancies, comprising 39% 
(95% CrI 32–46) of the total placental-infection-attributable 
LBW burden. This risk is also subject to the greatest 
degree of spatial heterogeneity, with estimates of 
malaria-attributable risk of LBW ranging from more than 
12% in areas of very high prevalence (above 70% slide 
prevalence in ages 2–10 years) such as inland west Africa 
and northern Mozambique to less than 1∙5% in areas 
where the same population prevalence is less than 10% 
(ﬁ gure 4A; table 1). Assuming our model of LBW risk also 
holds for seasonal settings, our sensitivity analysis of 
seasonality (appendix) suggests that these results are 
generally insensitive to variation in transmission 
throughout the year.
In second and subsequent pregnancies, parity-
dependent immunity reduces the burden of infection and 
reduces spatial heterogeneity in LBW risk, with women in 
high transmission areas acquiring a greater degree of 
immunity than those in less-intense settings. As a result, 
by their third pregnancy, pregnant women are estimated 
to be at very similar low levels of malaria-attributable LBW 
risk (2–4%) in all areas of moderate-to-high transmission 
(more than 10% 2–10-year-old prevalence; table 1). This 
parity-dependent pattern also means that patterns of 
fertility might cause substantial spatial variation in overall 
per-pregnancy risk of LBW, with areas where women have 
a low mean number of lifetime pregnancies having a 
higher burden of LBW per pregnancy than areas where 
women have a high mean number of pregnancies, due to 
the higher relative proportion of primigravidae and 
secundigravidae (appendix).
The overall numbers of infected pregnancies and 
malaria-attributable LBW deliveries have a similar 
geographical pattern (appendix), with the largest burden 
occurring in areas where high levels of transmission 
coincide with high population density.
Discussion
Our estimates are the ﬁ rst of the distribution of the 
parity-speciﬁ c risk of placental sequestration in Africa, 
and the only contemporary estimates of the corresponding 
malaria-associated risk of LBW (panel). We estimated 
that, in the absence of pregnancy-speciﬁ c interventions, 
12∙4 million women delivering live babies (44∙9% of all 
liveborn deliveries) would be exposed to infection capable 
of sequestering within the placenta. When we applied our 
estimates of parity-dependent immunity, which can 
prevent placental infection, and the risk of LBW, this 
translated into 11∙4 million (41∙2%) placental infections 
and 900 000 (3∙3%) LBW deliveries. This burden estimate 
does not include the eﬀ ect of symptomatic malaria and its 
eﬀ ect on the risk of preterm delivery in women without 
immunity in areas of low transmission intensity,2,23 which 
might modify the relation between malaria-attributable 
LBW and the risk of neonatal mortality.24 However, 
because we estimate that only 6% of pregnancies exposed 
to malaria occur in areas of Africa with prevalence lower 
than 10%, this number might not contribute substantially 
Figure 4: Spatial distribution of estimated risk of placental-malaria-attributable low birthweight (LBW)
Maps show the LBW risk per delivery for ﬁ rst (A), second (B), and third (C) pregnancies, and the same measure 
averaged over all gravidities (D). Map (D) is presented on a diﬀ erent colour scheme from A–C to show spatial 
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 Panel: Research in context
Systematic review 
We searched PubMed (date last search done Sept 2, 2013) with no date limits or language 
restrictions using the search terms “malaria”, “burden”, AND “pregnancy” to identify 
previous estimates of the number of pregnancies aﬀ ected by malaria and the associated 
burden of low birthweight in Africa. This identiﬁ ed three key studies. The most recent 
study4 used estimates of the distribution of Plasmodium falciparum parasite prevalence to 
estimate pregnancies and livebirths at risk, but did not estimate the risk of placental 
infection or the burden of low birthweight attributable to P falciparum malaria. The two 
older studies6,7 did estimate these quantities, but are now more than 10 years old and 
hence do not capture the heterogeneity in transmission that occurs across Africa, nor the 
extent to which this has changed in recent years. We therefore sought to capture these 
important aspects to obtain contemporary estimates of burden. 
Interpretation
We estimate that the exposure to, and risk of, placental infection increases with 
transmission intensity. At the same time, pregnant women develop increasing immunity 
with exposure to malaria through successive pregnancies, such that the overall attributable 
burden of LBW women have throughout child-bearing age is similar in all areas of 
moderate-to-high transmission, decreasing as the prevalence of infection in the population 
reduces to less than 10%. A large proportion of this burden is estimated to be due to 
infections acquired early in or before pregnancy. Protection of women from malaria in 
pregnancy should therefore be a public-health priority, and increased focus should be placed 
on adequate protection of women early in, or immediately before, their ﬁ rst pregnancy.
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to LBW burden relative to the eﬀ ect of chronic 
asymptomatic infection in higher transmission settings. 
Our estimates suggest that primigravidae, who have yet 
to acquire parity-dependent immunity, have a slightly 
higher risk of placental infection than do multigravidae, 
but that the progression of infection is the main 
contributor to the disproportionate level of malaria-
attributable LBW they experience. In particular we noted 
that the high risk of prolonged chronic infection in 
women without pregnancy-speciﬁ c immunity as 
estimated by our model, and evidenced by a much higher 
proportion of chronic infection in primigravidae at 
delivery,14 provides the best ﬁ t to patterns of LBW risk by 
parity and histology. A risk of LBW dependent on the 
chronicity of infection could also be partly due to the fact 
that these infections are likely to have occurred earlier in 
pregnancy (a factor captured in our model).
These estimates accord with ﬁ ndings from a 2011 study9 
that women infected early in pregnancy have a dis-
proportionately high risk of LBW, and suggests that 
clearing of infection as early in pregnancy as possible 
should be a priority. On the basis of our previous model 
ﬁ tting,14 the available evidence,22 and the peak in 
peripheral parasitaemia around the beginning of the 
second trimester,25 we assume that this susceptibility 
begins around the end of the ﬁ rst trimester, creating a 
discrete peak in the incidence of placental infection. 
Application of this model across Africa suggests that 
nearly two-thirds of infected pregnancies are infected 
around this point of gestation. This proportion is likely to 
be even greater when interventions such as intermittent 
preventive therapy, provided from the second trimester 
onwards, are taken into account. Taken together, our 
estimates suggest that clearance or prevention of 
infection during the ﬁ rst trimester, or soon before a 
woman becomes pregnant, is likely to have the largest 
eﬀ ect both on the number of women with placental 
infection and the LBW burden this creates.
Our estimates suggest that, because of the eﬀ ects of 
parity-dependent immunity, the overall per-pregnancy 
risk of LBW changes very gradually with increasing 
transmission intensity, with the risk becoming more 
concentrated in women who have had fewer pregnancies. 
If transmission has recently reduced, however, our 
estimates might temporarily overestimate LBW burden, 
because primigravidae are less likely to become infected 
than are multigravidae, whereas multigravidae maintain 
a level of immunity acquired at a time when transmission 
was more intense. Instead, in areas where this is true, 
our estimates should be interpreted as the risk a woman 
starting her ﬁ rst pregnancy is likely to have throughout 
her lifetime if transmission rates are constant.
This estimate of the relation between placental infection 
and the burden of LBW is based on data from only two sites 
because these were the only available large-scale datasets to 
our knowledge that provide the risk of LBW by parity and 
the histological stage of infection before the introduction of 
insecticide-treated nets or intermittent preventive therapy. 
This relation would be likely to replicate similar patterns of 
LBW risk by placental histology to those observed in 
smaller datasets from other settings.25,26 However, the 
assumption that our estimates can be extended to all of 
Africa is impossible to validate. Our estimates also ignore 
various heterogeneities that could aﬀ ect the probability of 
infection and associated LBW risk, such as the distribution 
of sickle-cell trait, glucose-6-phosphate dehydrogenase 
deﬁ ciency,27 and maternal undernutrition, which vary by 
region. Similarly, any seasonality in fertility could also 
aﬀ ect the overall risk of infection and burden of LBW in 
seasonal transmission settings. However, the most 
important factor not included in the model is HIV infection, 
which disrupts the development of parity-dependent 
immunity, leaving women of high parity with HIV at 
similar susceptibility to placental malaria as during their 
ﬁ rst pregnancies.28 Our model was ﬁ tted to data from areas 
of similar HIV prevalence (8∙5% among pregnant women 
in Kiliﬁ ,13 and 6∙5% in Ifakara12). This consistency could 
aﬀ ect the generalisability of our model to areas of lower 
prevalence such as west Africa, and of higher prevalence 
such as southern Africa. However, despite these limitations, 
we do seem to have captured many of the most fundamental 
aspects of the epidemiology of placental infection in areas 
of sustained transmission that have not been previously 
incorporated into estimates of the burden of malaria in 
pregnancy in Africa.4,6 These include parity-dependent 
reductions in susceptibility to placental infection depending 
on infection during previous pregnancies,1–3 the importance 
of early infection,9.10 which might clear by delivery, and the 
inﬂ ammatory reaction within the placenta associated with 
chronic infection.3
In conclusion, despite documented reductions in malaria 
transmission in various parts of Africa,29 the burden of 
placental infection in unprotected pregnant women 
remains. This draws attention to the need to maintain high 
levels of intervention coverage in pregnant women during 
the transition to universal coverage. Our results also 
suggest that measures that reduce exposure to infection in 
the early stages of, or immediately before, pregnancy, such 
as insecticide-treated nets, are likely to be very eﬀ ective in 
prevention of placental infection and corresponding LBW, 
especially in women during their ﬁ rst pregnancy.
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